PSY182 - A TARGETED REVIEW OF HAEMATOLOGY SINGLE TECHNOLOGY APPRAISALS (STAS) BY NICE SINCE THE INTRODUCTION OF THE NEW CANCER DRUGS FUND (CDF)
Oct 1, 2018, 00:00
10.1016/j.jval.2018.09.2756
https://www.valueinhealthjournal.com/article/S1098-3015(18)36058-3/fulltext
Title :
PSY182 - A TARGETED REVIEW OF HAEMATOLOGY SINGLE TECHNOLOGY APPRAISALS (STAS) BY NICE SINCE THE INTRODUCTION OF THE NEW CANCER DRUGS FUND (CDF)
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(18)36058-3&doi=10.1016/j.jval.2018.09.2756
First page :
Section Title :
Open access? :
No
Section Order :
2112